Abstract CN73
Background
Hand-foot syndrome (HFS), may cause sensory loss, erythema-specific skin syndrome, hand and foot skin pigmentation, swelling in finger, toes, blisters, ulcers, and bleeding with pain. Studies have found that some patients underestimate the potential long-term effects of the disease, which results in suboptimal disease management. The study aimed to explore the self-management of symptoms in patients with chemotherapy-induced HFS and to provide guidance for developing a self-management plan that aligns with patient needs.
Methods
Twenty-two patients who developed chemotherapy-induced HFS were selected by objective sampling from July to Sept 2022 in the Department of Oncology of a tertiary hospital in Shanghai. A semistructured face-to-face in-depth interview was performed to collect the case data, which were analyzed using the content analysis method, and the themes were refined.
Results
Twenty-two patients, were interviewed. Three themes and six subthemes emerged from analysis of the interviews: The first theme was “Patients’ attitudes and emotional responses to symptoms,” including patients gradually accepted the symptoms of HFS and adapted to some mild manifestations based on the following responses, showed different emotional responses to the HFS, symptoms that affected their daily lives. Patient felt guilty for his family and had a self-image disorder. The second theme was “symptom experience,” symptoms varied across patients and had different impacts on individual lives. Including pain and itching feeling peeling. The third theme was “coping strategies,” including patients felt the impact of limited social interaction and family relationships. The fourth theme was “expectations for the future,” including acquire related knowledge via websites, physicians, and among patients, changed habits and showed improved symptoms and met/exceeded the expectations of the healthcare providers.
Conclusions
Healthcare providers should offer more education and emotional support to patients with chemotherapy-induced HFS to achieve symptom management, elicit positive experiences, and help with more targeted and effective self-management of symptoms.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
CN48 - Mobile response and prevention unit: Mobile information and management unit a collaboration between “Care In Adult Cancer Patients” nursing research laboratory and “Cancer Guidance Center” a non-profit organization (Kapa3)
Presenter: Evangeli Bista
Session: Poster session 25
Resources:
Abstract
CN49 - Nurse–patient sexual health communication in gynecological cancer follow-up: A qualitative study from nurses’ perspectives
Presenter: Anita Paulsen
Session: Poster session 25
Resources:
Abstract
CN50 - Patient-reported outcome measures and supportive care need assessment in patients in a slovenian tertiary oncology centre
Presenter: Majda Causevic
Session: Poster session 25
Resources:
Abstract
CN51 - Psychometric properties of the Turkish version of the nurse spiritual therapeutic scale for oncology patients and caregivers
Presenter: Remziye Semerci
Session: Poster session 25
Resources:
Abstract
CN52 - Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects
Presenter: Ariadna Garcia Rodriguez
Session: Poster session 25
Resources:
Abstract
CN53 - Sexual function in survivors of hematological malignancy and autologous hematopoietic stem cell transplantation
Presenter: Ioanna Tsatsou
Session: Poster session 25
Resources:
Abstract
CN54 - Sexual health in women with breast cancer undergoing hormonal treatment
Presenter: Cristina Tebar
Session: Poster session 25
Resources:
Abstract
CN55 - The impact of psychosocial support on the overall health of cancer patients in the COVID-19 era
Presenter: Gianluca Catania
Session: Poster session 25
Resources:
Abstract
CN56 - Well-being and healthcare concerns of patients with advanced renal cell carcinoma: The RCC PROMs international survey
Presenter: Grigorios Kotronoulas
Session: Poster session 25
Resources:
Abstract
CN57 - Patients, informal caregivers and healthcare professionals experience in adoptive cell therapies: An experience-based co-design study (EBCD-ACT)
Presenter: Canova Canova
Session: Poster session 25
Resources:
Abstract